RxDoctor Payments Data

Juvvala Reddy, MD

Psychiatry · Patton, CANPI 1205919503

Payments from drug & device makers

$2,934in general payments, 2019–2025

Across 170 payments — averaging $17.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$930
  • AbbVie$652
  • Otsuka America Pharmaceutical, Inc.$303
  • Teva Pharmaceuticals USA, Inc.$158
  • Corium, LLC$111
  • Lundbeck LLC$99
  • plus $682 from 14 others

What the payments were for

  • Food & beverage$2,922100%
  • Education$120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,934 in reported general payments places this provider in the 85th percentile of 4,954 psychiatry providers in California.

See all psychiatry providers in California

Medicare billing

Part B allowed, 2024
$16,797
Medicare patients
25
Services billed
184

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole65$94,925
VraylarCariprazine Hcl19$27,348
CaplytaLumateperone Tosylate11$16,552
TrintellixVortioxetine Hydrobromide30$14,577
Selegiline Hcl12$3,362
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine66$1,224
Riluzole12$1,204
Trazodone Hcl85$1,142
Clonazepam41$897
Escitalopram Oxalate140$837
Bupropion XlBupropion Hcl52$703
Quetiapine Fumarate36$546
Aripiprazole18$546
Olanzapine44$480
Alprazolam115$464

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti$303$94,92565 claims
AbbVieVraylar$652$27,34819 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$930$16,55211 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$81$14,57730 claims
Almatica Pharma LLCSertraline Hcl$45$15849 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,954 psychiatry providers in California.

Other psychiatry in Patton

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →